The BioVox White Paper on Cancer Immunotherapy showcases innovators and world leaders in this exciting field, including GSK Biologicals, Janssen Immunosciences, Celyad, RXi Pharmaceuticals, eTheRNA, ImmunXperts, iTeos Therapeutics and PDC*line Pharma.
In this issue:
- Why is immunotherapy more than the latest hype?
- What are the challenges to bring lifesaving innovations to the patient
- The price of life: who will pay for these treatments?
- Pioneering immunotherapy companies in the picture
- Insight in landmark oncology trials
- Academic innovations in immunotherapy
You may download the White Paper here: